Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1995-06-07
1999-05-18
Ketter, James
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424499, 424502, 514 2, 530351, A61K9/14;9/50;38/21
Patent
active
059049359
ABSTRACT:
The present invention provides improved compositions for improving the chemical and physical stability of peptides and proteins. The invention provides a liquid beneficial agent formulation containing a liquid suspension comprising at least 5% by weight beneficial agent and having a viscosity and beneficial agent size which minimizes settling of the agent in suspension over the extended delivery period.
REFERENCES:
patent: 3732865 (1973-05-01), Higuchi et al.
patent: 3833725 (1974-09-01), Thompson et al.
patent: 4036954 (1977-07-01), Murakami et al.
patent: 4180560 (1979-12-01), Katz et al.
patent: 4215691 (1980-08-01), Wong
patent: 4237885 (1980-12-01), Wong et al.
patent: 4389414 (1983-06-01), Kent
patent: 4475916 (1984-10-01), Himmelstein
patent: 4483849 (1984-11-01), Carter et al.
patent: 4507281 (1985-03-01), Asculai et al.
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4675381 (1987-06-01), Bichon
patent: 4834985 (1989-05-01), Elger et al.
patent: 4847079 (1989-07-01), Kwan
patent: 4855141 (1989-08-01), Eckenhoff et al.
patent: 4871538 (1989-10-01), Yim et al.
patent: 4942035 (1990-07-01), Churchill et al.
patent: 4954342 (1990-09-01), Lattanzi et al.
patent: 5032572 (1991-07-01), Saffran et al.
patent: 5034229 (1991-07-01), Magruder et al.
patent: 5047396 (1991-09-01), Orban et al.
patent: 5057318 (1991-10-01), Magruder et al.
patent: 5081156 (1992-01-01), Yamshira et al.
patent: 5096926 (1992-03-01), Fiorini et al.
patent: 5110596 (1992-05-01), Magruder et al.
patent: 5122376 (1992-06-01), Aliverti et al.
patent: 5137727 (1992-08-01), Eckenhoff
patent: 5211950 (1993-05-01), Kobayashi et al.
patent: 5221278 (1993-06-01), Linkwitz et al.
patent: 5223265 (1993-06-01), Wong
patent: 5236707 (1993-08-01), Stewart, II
patent: 5324518 (1994-06-01), Orth et al.
patent: 5342625 (1994-08-01), Haurr et al.
patent: 5360616 (1994-11-01), Garza-Flores et al.
patent: 5614487 (1997-03-01), Battersby et al.
patent: 5735897 (1998-04-01), Buirge
DNA, "Efficient Bacterial Expression of Bovine and Procine Growth Hormones," Seeburg et al, vol. 2, No. 1, 1983, pp. 37-45, Mary Ann Liebert, Inc., Publishers.
Nuclieic Acids Research, "Cloning and nucleotide sequencing of the bovine growth hormone gene," Woychik et al, vol. 10, No. 22, 1982, pp. 7197-7210. IRL Press Limited, Oxford, England.
"The Pharmacological Basis of Therapeutics," by Goodman & Gilman, 7th Ed., (1985) pp. 1430-1439.
Carr John P.
Eckenhoff, deceased James B.
Holladay Leslie A.
Leonard, Jr. John Joseph
Leung Iris K. M.
ALZA Corporation
Clarke Pauline Ann
Dillahunty Mary Ann
Ketter James
Sandals William
LandOfFree
Peptide/protein suspending formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide/protein suspending formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide/protein suspending formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1758613